Breaking News Instant updates and real-time market news.

CDXC

ChromaDex

$3.41

0.41 (13.67%)

06:41
10/17/19
10/17
06:41
10/17/19
06:41

ChromaDex reports new study on nicotinamide riboside importance

ChromaDex announced results of a preclinical study conducted by Nestle published last month in the journal Nature Communications, a peer-reviewed open access scientific journal published by the Nature Publishing Group. The study investigated the impact on the liver when its cells lose the ability to use the nutrient nicotinamide riboside, or NR. The preclinical study concluded that the tissue's natural ability to utilize NR is important for maintaining resilience during periods of metabolic stress such as a high-fat diet. It is also the first study to show the physiological consequences that arise when cells lose the ability to use NR. In December 2018, ChromaDex entered into a license and supply agreement for Niagen, or nicotinamide riboside, with Nestle Health Science. The body uses NR to boost nicotinamide adenine dinucleotide, or NAD, a molecule found in cells that powers metabolism and helps cells be more resilient in the face of metabolic stress.

CDXC ChromaDex
$3.41

0.41 (13.67%)

02/14/19
RILY
02/14/19
INITIATION
Target $7
RILY
Buy
ChromaDex initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Jeff Van Sinderen started ChromaDex with a Buy rating and $7 price target. The analyst says the company's bioscience-based products support better aging and enhanced performance.
10/15/19
OPCO
10/15/19
INITIATION
Target $6
OPCO
Outperform
ChromaDex initiated with an Outperform at Oppenheimer
Oppenheimer analyst Brian Nagel initiated coverage of ChromaDex with an Outperform rating and $6.00 price target.
10/16/19
10/16/19
INITIATION
Target $6

Outperform
Oppenheimer bullish on ChromaDex, initiates with an Outperform
As previously reported, Oppenheimer analyst Brian Nagel initiated coverage of ChromaDex with an Outperform rating and $6.00 price target. The analyst is "increasingly optimistic" that, as management continues to develop and refine its marketing message, sales of NIAGEN to consumers worldwide should pick up significantly, effectively leveraging a largely capital-light corporate infrastructure.
10/16/19
10/16/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Verizon (VZ), Comcast (CMCSA), and AT&T (T) initiated with Market Perform ratings at Bernstein. 2. Inovalon (INOV) initiated with a Buy at Citi. 3. Assembly Biosciences (ASMB) initiated with a Buy at Mizuho. 4. ChromaDex (CDXC) initiated with an Outperform at Oppenheimer. 5. Axsome Therapeutics (AXSM) initiated with a Buy at Guggenheim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

JCP

J.C. Penney

$1.10

0.01 (0.92%)

07:36
11/15/19
11/15
07:36
11/15/19
07:36
Hot Stocks
J.C. Penney expects liquidity to be at least $1.5B for remainder of the year »

The Company ended the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

CELG

Celgene

$110.03

-0.42 (-0.38%)

07:35
11/15/19
11/15
07:35
11/15/19
07:35
Hot Stocks
Celgene receives positive CHMP opinion for REVLIMID »

Celgene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 07

    Dec

  • 25

    Mar

  • 04

    Apr

JCP

J.C. Penney

$1.10

0.01 (0.92%)

07:35
11/15/19
11/15
07:35
11/15/19
07:35
Hot Stocks
J.C. Penney CEO says 'made significant progress' on efforts to return to growth »

"The past quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

BABA

Alibaba

$182.69

0.21 (0.12%)

, STAY

Extended Stay America

$14.69

0.12 (0.82%)

07:35
11/15/19
11/15
07:35
11/15/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BABA

Alibaba

$182.69

0.21 (0.12%)

STAY

Extended Stay America

$14.69

0.12 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

AMAT

Applied Materials

$56.89

-0.24 (-0.42%)

07:35
11/15/19
11/15
07:35
11/15/19
07:35
Recommendations
Applied Materials analyst commentary  »

Applied Materials price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Dec

  • 09

    Dec

JCP

J.C. Penney

$1.10

0.01 (0.92%)

07:33
11/15/19
11/15
07:33
11/15/19
07:33
Hot Stocks
J.C. Penney expects FY19 adjusted EBITDA to exceed $475M »

In addition, the Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

RIGL

Rigel Pharmaceuticals

$2.29

-0.065 (-2.77%)

07:32
11/15/19
11/15
07:32
11/15/19
07:32
Hot Stocks
Rigel Pharmaceuticals receives positive CHMP opinion for fostamatinib »

Rigel Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

JCP

J.C. Penney

$1.10

0.01 (0.92%)

07:32
11/15/19
11/15
07:32
11/15/19
07:32
Hot Stocks
J.C. Penney reports Q3 SSS down 9.3% »

Adjusted comparable store…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

CGC

Canopy Growth

$15.84

-2.68 (-14.47%)

07:32
11/15/19
11/15
07:32
11/15/19
07:32
Recommendations
Canopy Growth analyst commentary  »

Canopy Growth price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

JCP

J.C. Penney

$1.10

0.01 (0.92%)

07:31
11/15/19
11/15
07:31
11/15/19
07:31
Earnings
J.C. Penney reports Q3 adjusted EPS (30c), consensus (55c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ADS

Alliance Data

$106.55

-0.57 (-0.53%)

07:31
11/15/19
11/15
07:31
11/15/19
07:31
Hot Stocks
Alliance Data reports October net charge offs 6.6% vs. 5.3% last month »

Reports October…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMAT

Applied Materials

$56.89

-0.24 (-0.42%)

07:31
11/15/19
11/15
07:31
11/15/19
07:31
Recommendations
Applied Materials analyst commentary  »

Applied Materials price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Dec

  • 09

    Dec

TORC

resTORbio

$7.93

-0.47 (-5.60%)

07:31
11/15/19
11/15
07:31
11/15/19
07:31
Hot Stocks
Breaking Hot Stocks news story on resTORbio 

resTORbio trading resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTCH

Farfetch

$7.49

-0.54 (-6.72%)

07:30
11/15/19
11/15
07:30
11/15/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$120.65

-0.41 (-0.34%)

07:28
11/15/19
11/15
07:28
11/15/19
07:28
Recommendations
Walmart analyst commentary  »

Walmart price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTCH

Farfetch

$7.49

-0.54 (-6.72%)

07:26
11/15/19
11/15
07:26
11/15/19
07:26
Recommendations
Farfetch analyst commentary  »

Farfetch price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$21.49

(0.00%)

07:25
11/15/19
11/15
07:25
11/15/19
07:25
Hot Stocks
Breaking Hot Stocks news story on Amarin »

Amarin shares up 21c to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

GLPG

Galapagos

$183.48

-7.74 (-4.05%)

, GILD

Gilead

$63.79

0.46 (0.73%)

07:25
11/15/19
11/15
07:25
11/15/19
07:25
Recommendations
Galapagos, Gilead analyst commentary  »

Galapagos price target…

GLPG

Galapagos

$183.48

-7.74 (-4.05%)

GILD

Gilead

$63.79

0.46 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 21

    Feb

VAR

Varian Medical

$125.01

0.45 (0.36%)

07:25
11/15/19
11/15
07:25
11/15/19
07:25
Conference/Events
Varian Medical to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

OCUL

Ocular Therapeutix

$2.67

-0.1 (-3.61%)

07:23
11/15/19
11/15
07:23
11/15/19
07:23
Recommendations
Ocular Therapeutix analyst commentary  »

Ocular Therapeutix price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNP

CenterPoint Energy

$26.68

-1.42 (-5.05%)

07:23
11/15/19
11/15
07:23
11/15/19
07:23
Downgrade
CenterPoint Energy rating change  »

CenterPoint Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBLX

Noble Midstream

$22.29

-0.36 (-1.59%)

07:22
11/15/19
11/15
07:22
11/15/19
07:22
Recommendations
Noble Midstream analyst commentary  »

Noble Midstream price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASB

Associated Banc-Corp

$21.43

-0.08 (-0.37%)

07:22
11/15/19
11/15
07:22
11/15/19
07:22
Conference/Events
Associated Banc-Corpmanagement to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 18

    Nov

NVDA

Nvidia

$209.88

1.33 (0.64%)

07:21
11/15/19
11/15
07:21
11/15/19
07:21
Upgrade
Nvidia rating change  »

Nvidia upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 06

    Jan

NCNA

NuCana

$5.59

-0.35 (-5.89%)

07:21
11/15/19
11/15
07:21
11/15/19
07:21
Recommendations
NuCana analyst commentary  »

NuCana price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.